In addition to a comprehensive analysis of vascular changes in the subcutaneous Myc-CaP model, we also detected castration-induced hypoxia in a genetically engineered PTEN-deficient prostate cancer model (Figure 5). This evidence concerns the gene PTEN and Familial prostate cancer.